Related Experiment Video
Updated: Jul 14, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
Sandra Tuyaerts1, Joeri L Aerts, Jurgen Corthals
1Laboratory of Molecular and Cellular Therapy, Department of Physiology and Immunology, Medical School of the Vrije Universiteit Brussel, Laarbeeklaan 103/E, 1090, Brussels, Belgium.
Cancer Immunology, Immunotherapy : CII
|May 16, 2007
Summary
Dendritic cell (DC) cancer immunotherapy shows promise, with ongoing research optimizing DC preparation and immune monitoring for improved clinical trials. Early results support DC use in future standardized cancer treatments.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Tumor-associated antigens and dendritic cell (DC) biology provide a basis for cancer immunotherapy.
- DC-based cancer vaccines aim to harness the immune system against tumors.
Purpose of the Study:
- To review recent advancements in dendritic cell (DC) generation for cancer immunotherapy.
- To discuss antigen loading techniques and immunomonitoring strategies for DC-based clinical trials.
Main Methods:
- Review of current literature on clinical DC generation and preparation.
- Analysis of antigen loading methods for enhancing DC immunogenicity.
- Evaluation of immunomonitoring approaches in DC-based cancer trials.
Main Results:
- Dendritic cell vaccination is an evolving field with continuous optimization of methods.
- Valuable proof-of-principle data support the use of DCs in future clinical trials.
- Improvements in immunomonitoring necessitate careful trial design.
Conclusions:
- Recent developments in DC generation, antigen loading, and immunomonitoring are crucial for advancing DC-based cancer immunotherapy.
- Further standardization of clinical trials is needed to fully realize the potential of dendritic cell vaccines.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.